Atara Biotherapeutics
ATRA
$0.51
Share price
-3.13%
Change (1 day)
-74.58%
Change (1 year)
Categories
Atara Biotherapeutics (ATRA) - Net assets
Net assets on the balance sheet as of March 2024 : -$98.31 M
According to Atara Biotherapeutics's latest financial reports the company has -$98.31 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Atara Biotherapeutics - Net assets on balance sheet (from 2013 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $0.12 B | -54.71% |
| 2021-12-31 | $0.27 B | -39.52% |
| 2020-12-31 | $0.46 B | 59% |
| 2019-12-31 | $0.29 B | -14.19% |
| 2018-12-31 | $0.33 B | 90.51% |
| 2017-12-31 | $0.17 B | -29.9% |
| 2016-12-31 | $0.25 B | -19.47% |
| 2015-12-31 | $0.31 B | 205.38% |
| 2014-12-31 | $0.10 B | -1036.57% |
| 2013-12-31 | $-11.02 M | 195.6% |
| 2012-12-31 | $-3.73 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 ImmunoGen
IMGN | $0.56 B | -671.26% | 🇺🇸 USA |
 Agenus
AGEN | -$0.2 B | 93.60% | 🇺🇸 USA |
 Affimed
AFMD | $63.91 M | -165.01% | 🇩🇪 Germany |